title: Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy.
authors.forename: Raoudha
authors.initials: R
authors.lastname: Dachraoui
authors.forename: Agnès
authors.initials: A
authors.lastname: Depatureaux
authors.forename: Mohamed
authors.initials: M
authors.lastname: Chakroun
authors.forename: Imène
authors.initials: I
authors.lastname: Fodha
authors.forename: Amel
authors.initials: A
authors.lastname: Letaief
authors.forename: Abdelhalim
authors.initials: A
authors.lastname: Trabelsi
authors.forename: François
authors.initials: F
authors.lastname: Simon
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Plantier
mesh_terms: D015492:AIDS Serodiagnosis / Q000379:methods; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral; D015700:HIV Envelope Protein gp41 / Q000235:genetics; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014416:Tunisia / Q000453:epidemiology; D019562:Viral Load / Q000379:methods
chemical_list: D015700:HIV Envelope Protein gp41